000			01114 a2200349 4500
005			20250514214938.0
264		0	_c20050302
008			200503s 0 0 eng d
022			_a0362-1332
040			_aNLM _beng _cNLM
245	0	0	_aTreatment options for HIV, AIDS. _h[electronic resource]
260			_bFDA consumer _c
300			_a4 p. _bdigital
500			_aPublication Type: News
650	0	4	_aAdipose Tissue
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aConnective Tissue Diseases _xdrug therapy
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDideoxynucleosides
650	0	4	_aDrug Combinations
650	0	4	_aEmtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
650	0	4	_aFace
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHIV-1
650	0	4	_aHumans
650	0	4	_aLactic Acid _xtherapeutic use
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aOrganophosphorus Compounds _xtherapeutic use
650	0	4	_aPolyesters
650	0	4	_aPolymers _xtherapeutic use
773	0		_tFDA consumer _gvol. 38 _gno. 6 _gp. 4
999			_c15352912 _d15352912